deltorphin ii, ala(2)- has been researched along with etorphine in 1 studies
Studies (deltorphin ii, ala(2)-) | Trials (deltorphin ii, ala(2)-) | Recent Studies (post-2010) (deltorphin ii, ala(2)-) | Studies (etorphine) | Trials (etorphine) | Recent Studies (post-2010) (etorphine) |
---|---|---|---|---|---|
233 | 0 | 20 | 798 | 23 | 63 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, C; Chong, PL; Huang, P; Liu-Chen, LY; Xu, W; Yoon, SI | 1 |
1 other study(ies) available for deltorphin ii, ala(2)- and etorphine
Article | Year |
---|---|
Cholesterol reduction by methyl-beta-cyclodextrin attenuates the delta opioid receptor-mediated signaling in neuronal cells but enhances it in non-neuronal cells.
Topics: Animals; Anticholesteremic Agents; beta-Cyclodextrins; Brain; Caveolin 1; Cell Line, Tumor; CHO Cells; Cholesterol; Cricetinae; Cricetulus; Diprenorphine; Enkephalin, D-Penicillamine (2,5)-; Etorphine; G(M1) Ganglioside; Hybrid Cells; Levorphanol; Membrane Microdomains; Membrane Proteins; Naloxone; Neurons; Oligopeptides; Receptors, Opioid, delta; Signal Transduction | 2007 |